Streptomyces from traditional medicine: sources of new innovations in antibiotic discovery
GA Quinn, AM Banat… - Journal of medical …, 2020 - microbiologyresearch.org
Given the increased reporting of multi-resistant bacteria and the shortage of newly approved
medicines, researchers have been looking towards extreme and unusual environments as a …
medicines, researchers have been looking towards extreme and unusual environments as a …
Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents
MS Bader, M Loeb, D Leto, AA Brooks - Postgraduate medicine, 2020 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited treatment options. Knowledge of the common uropathogens …
growing concern due to limited treatment options. Knowledge of the common uropathogens …
[HTML][HTML] Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems
Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging
problems - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
problems - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Nitrofurantoin: properties and potential in treatment of urinary tract infection: a narrative review
M Mahdizade Ari, S Dashtbin, F Ghasemi… - Frontiers in cellular …, 2023 - frontiersin.org
Nitrofurantoin (NF), a wide-spectrum antibiotic accessible since 1953, is utilized widely to
treat urinary tract infections as it usually stays active against drug-resistant uropathogen. The …
treat urinary tract infections as it usually stays active against drug-resistant uropathogen. The …
The challenge of urinary tract infections in renal transplant recipients
I Hollyer, MG Ison - Transplant Infectious Disease, 2018 - Wiley Online Library
Urinary tract infections (UTI) are an important cause of morbidity and mortality in renal
transplant patients. These infections are quite common, and the goal of care is to identify …
transplant patients. These infections are quite common, and the goal of care is to identify …
ESBL-producing Escherichia coli and its rapid rise among healthy people
K Kawamura, N Nagano, M Suzuki, J Wachino… - Food Safety, 2017 - jstage.jst.go.jp
Since around the 2000s, Escherichia coli (E. coli) resistant to both oxyimino-cephalosporins
and fluoroquinolones has remarkably increased worldwide in clinical settings. The kind of E …
and fluoroquinolones has remarkably increased worldwide in clinical settings. The kind of E …
Community-acquired lower urinary tract infections: Etiology, antimicrobial resistance, and treatment results in female patients
Objective: The aim of the present study is to determine the distribution of bacterial strains
isolated from lower UTIs and their resistance patterns against commonly used antimicrobial …
isolated from lower UTIs and their resistance patterns against commonly used antimicrobial …
Fosfomycin and nitrofurantoin: classic antibiotics and perspectives
Antibiotics are essential molecules for the treatment and prophylaxis of many infectious
diseases. However, drugs that combat microbial infections can become a human health …
diseases. However, drugs that combat microbial infections can become a human health …
Genomic insights into nitrofurantoin resistance mechanisms and epidemiology in clinical Enterobacteriaceae
J Osei Sekyere - Future science OA, 2018 - Taylor & Francis
Aim: Multidrug-resistant enterobacteria are highly associated with invasive devices and
intensive care units. Increasing resistance to carbapenems is leading to the use of older and …
intensive care units. Increasing resistance to carbapenems is leading to the use of older and …
Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: a real-world perspective and review of the literature
Among 47 patients with urinary tract infections (UTIs) due to multidrug-resistant (MDR)
bacteria, treatment with fosfomycin resulted in clinical cure rates of 87% and 94% at 48 …
bacteria, treatment with fosfomycin resulted in clinical cure rates of 87% and 94% at 48 …